What is the price of Emerald health Therapeutics'stock?
Since then, EMH stock has increased by 41.7% and is now trading at C$0.26. View which stocks have been most impacted by COVID-19. How were Emerald Health Therapeutics' earnings last quarter? Emerald Health Therapeutics, Inc. (CVE:EMH) released its quarterly earnings results on Monday, November, 29th.
What does Emerald health Therapeutics's P/E ratio mean?
The P/E ratio of Emerald Health Therapeutics is -0.37, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings. The P/E ratio of Emerald Health Therapeutics is -0.37, which means that its earnings are negative and its P/E ratio cannot be compared to companies with positive earnings.
Will Emerald health Therapeutics (emhtf) underperform the S&P 500?
Vote “Underperform” if you believe EMHTF will underperform the S&P 500 over the long term. You may vote once every thirty days. Emerald Health Therapeutics does not currently pay a dividend.
Is emerald health Therapeutics available in Nova Scotia?
Emerald Health Therapeutics Expands Adult-Use Cannabis Product Distribution to Nova Scotia VANCOUVER, British Columbia, Oct. 22, 2019 -- Emerald Health Therapeutics, Inc. (“Emerald”) (TSXV: EMH; OTCQX: EMHTF) has fulfilled its first shipment of premium cannabis.
Is Emerald Health Therapeutics a good buy?
Assuming the 90 days horizon and your typical level of risk aversion, our recommendation regarding Emerald Health Therapeutics is 'Strong Sell'.
Is Emhtf a good stock to buy?
Therefore, we hold a negative evaluation of this stock. Due to some small weaknesses in the technical picture we have downgraded our analysis conclusion for this stock since the last evaluation from a Buy to a Sell candidate.
Is Emerald a good stock to buy?
Emerald Health Therapeutics is a small-cap stock with a high ceiling, which has attracted its fair share of would-be investors. The company has already demonstrated that it's capable of strong and rapid growth.
What does Emerald Health Therapeutics do?
Emerald Health Therapeutics, Inc., together with its subsidiaries, engages in the production and sale of medical cannabis for medical purpose in Canada. It offers dried cannabis strains, pre-rolls, ingestible extracts, and cannabis oil products to its medical patients.
What happened Emerald Health?
Emerald Health grew rapidly with Canada's burgeoning cannabis industry but ultimately never made a profit in the sector. The company lost a total of CA$224.6 million between 2015 and June 2021. In that time, the company's workforce grew from a couple of dozen employees to 166 in 2019, then fell to 111 this year.
Is Emerald Health Pharmaceuticals publicly traded?
EHP is currently offering shares of Common Stock at $6.00 per share to both accredited and nonaccredited investors. The minimum investment is 500 shares, or $3,000. The Company's Offering Circular, which was qualified by the SEC on November 24, 2020, can be viewed by clicking here.
Is Emerald Health Pharmaceuticals a publicly traded company?
Emerald Health Pharmaceuticals Inc., a Delaware corporation (the Company, EHP, we, or our) is offering up to 10,000,000 (the Maximum Offering) shares (the Shares) of our Common Stock, par value $0.0001 per share (Common Stock) to be sold in this offering (the Offering)....Page.PageINDEX TO FINANCIAL STATEMENTSF-121 more rows
What are EMH health products?
PROFILE (EMH) operates as a cannabis company. The firm engages in the production distribution, and sale of cannabis products. Its products include dried cannabis and cannabis oil, pants and seeds.
How has Emerald Health Therapeutics' stock price performed in 2022?
Emerald Health Therapeutics' stock was trading at C$0.26 at the beginning of the year. Since then, EMH shares have increased by 0.0% and is now tra...
Who are Emerald Health Therapeutics' key executives?
Emerald Health Therapeutics' management team includes the following people: Dr. Avtar S. Dhillon , Exec. Chairman (Age 59, Pay $485.05k) Mr. Ria...
Who are some of Emerald Health Therapeutics' key competitors?
Some companies that are related to Emerald Health Therapeutics include Bioventix (BVXP) , Fennec Pharmaceuticals (FRX) , Agronomics (ANIC) , Re...
What other stocks do shareholders of Emerald Health Therapeutics own?
Based on aggregate information from My MarketBeat watchlists, some companies that other Emerald Health Therapeutics investors own include Aurora C...
What is Emerald Health Therapeutics' stock symbol?
Emerald Health Therapeutics trades on the Canadian Venture Exchange (CVE) under the ticker symbol "EMH."
How do I buy shares of Emerald Health Therapeutics?
Shares of EMH and other Canadian stocks can be purchased through an online brokerage account. Popular online brokerages with access to the Canadian...
What is Emerald Health Therapeutics' stock price today?
One share of EMH stock can currently be purchased for approximately C$0.26.
How much money does Emerald Health Therapeutics make?
Emerald Health Therapeutics (CVE:EMH) has a market capitalization of C$52.28 million and generates C$13.02 million in revenue each year.
How many employees does Emerald Health Therapeutics have?
Emerald Health Therapeutics employs 161 workers across the globe.
How has Emerald Health Therapeutics' stock price performed in 2022?
Emerald Health Therapeutics' stock was trading at $0.0450 at the start of the year. Since then, EMHTF shares have decreased by 17.8% and is now tra...
Are investors shorting Emerald Health Therapeutics?
Emerald Health Therapeutics saw a increase in short interest in May. As of May 31st, there was short interest totaling 423,400 shares, an increase...
Who are Emerald Health Therapeutics' key executives?
Emerald Health Therapeutics' management team includes the following people: Mr. Moe Jiwan , Chief Operating Officer Mr. Bernie Hertel , VP of Fi...
Who are some of Emerald Health Therapeutics' key competitors?
Some companies that are related to Emerald Health Therapeutics include 18564 (NBL.L) (NBL) , Cooper Energy (COPJF) , Crown Point Energy (CWVLF)...
What is Emerald Health Therapeutics' stock symbol?
Emerald Health Therapeutics trades on the OTCMKTS under the ticker symbol "EMHTF."
How do I buy shares of Emerald Health Therapeutics?
Shares of EMHTF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBu...
What is Emerald Health Therapeutics' stock price today?
One share of EMHTF stock can currently be purchased for approximately $0.04.
How many employees does Emerald Health Therapeutics have?
Emerald Health Therapeutics employs 110 workers across the globe.
What is Emerald Health Therapeutics' official website?
The official website for Emerald Health Therapeutics is www.emerald.care .
About Emerald Health Therapeutics
Emerald Health Therapeutics (CVE:EMH) Frequently Asked Questions
Emerald Health Therapeutics, Inc., together with its subsidiaries, produces and sells medical cannabis for medical purpose in Canada. The company is also involved in developing natural health products. It offers dried cannabis strains, pre-rolls, and cannabis oil products to its medical patients. The company was formerly known as T-Bird Pharma Inc.
How has Emerald Health Therapeutics' stock been impacted by COVID-19 (Coronavirus)?
Emerald Health Therapeutics' stock was trading at C$0.18 on March 11th, 2020 when COVID-19 reached pandemic status according to the World Health Organization. Since then, EMH stock has increased by 41.7% and is now trading at C$0.26. View which stocks have been most impacted by COVID-19.
Are investors shorting Emerald Health Therapeutics?
Emerald Health Therapeutics' stock was trading at $0.1450 on March 11th, 2020 when COVID-19 (Coronavirus) reached pandemic status according to the World Health Organization. Since then, EMHTF stock has decreased by 71.7% and is now trading at $0.0411. View which stocks have been most impacted by COVID-19.
Who are some of Emerald Health Therapeutics' key competitors?
Emerald Health Therapeutics saw a decline in short interest in January. As of January 15th, there was short interest totaling 13,400 shares, a decline of 82.3% from the December 31st total of 75,500 shares.
What is Emerald Health Therapeutics' stock symbol?
Some companies that are related to Emerald Health Therapeutics include 18564 (NBL.L) (NBL), Cooper Energy (COPJF), Crown Point Energy (CWVLF), Freehold Royalties (FRHLF), GASFRAC Energy Services (GSFVF), Gulf Coast Ultra Deep Royalty Trust (GULTU), Headwater Exploration (CDDRF), International Petroleum (IPCFF), Japan Petroleum Exploration (JPTXF), Leucrotta Exploration (LCRTF), Manitok Energy (MKRYF), Petro Matad (PRTDF), PetroShale (PSHIF), Pond Technologies (PNDHF) and Santos (STOSF). View all of EMHTF's competitors..
How do I buy shares of Emerald Health Therapeutics?
Emerald Health Therapeutics trades on the OTCMKTS under the ticker symbol "EMHTF."
What is Emerald Health Therapeutics' stock price today?
Shares of EMHTF can be purchased through any online brokerage account. Popular online brokerages with access to the U.S. stock market include WeBull, Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Robinhood, Fidelity, and Charles Schwab. Compare Top Brokerages Here.
What is Emerald Health Therapeutics' official website?
One share of EMHTF stock can currently be purchased for approximately $0.04.
HYTN Innovations Awarded Approval for the Sale of Cannabis to Provincially and Territorially Authorized Retailers
The official website for Emerald Health Therapeutics is www.emerald.care.
Emerald Health Therapeutics Sells Patents to FlowerPod
KELOWNA, British Columbia, Feb. 22, 2022 (GLOBE NEWSWIRE) -- HYTN Innovations Inc.
Emerald Health Therapeutics Reports 2021 AGM Results
Vancouver, British Columbia-- (Newsfile Corp. - January 11, 2022) - Emerald Health Therapeutics, Inc.
Emerald Health Therapeutics Pivots Out of Recreational and Medical Cannabis and into Pharmaceutical Development
Vancouver, British Columbia-- (Newsfile Corp. - December 31, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") has announced the results of voting at its annual general meeting held December 30, 2021.
Emerald Health Therapeutics and HYTN Cannabis to Launch Cannabis Beverages in Canada
Vancouver, British Columbia-- (Newsfile Corp. - November 29, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald" or the "Company") today announced that it is exiting the recreational and medical cannabis business and pivoting to a pharmaceutical development focus.
Emerald Health Therapeutics Strategic Licensee, FlowerPod, Unveils Groundbreaking Dose-Controlled Cannabis Vaping Product, New Brand, and U.S. Launch Plans
Emerald partners with HYTN to sell and distribute HYTN's calorie-free, fast-acting THC-infused sparkling cannabis beverages as new alternative in the rapidly growing cannabis beverage market Vancouver, British Columbia-- (Newsfile Corp. - November 3, 2021) - Emerald Health Therapeutics, Inc.
Emerald Health Therapeutics Announces Chief Financial Officer Transition
Emerald Patent Licensee Announces Partnership with Leading Cannabis Vaporization Technology Company, Grenco Science Vancouver, British Columbia-- (Newsfile Corp. - October 28, 2021) - Emerald Health Therapeutics, Inc.
Recently Viewed Tickers
Vancouver, British Columbia-- (Newsfile Corp. - September 10, 2021) - Emerald Health Therapeutics, Inc. (CSE: EMH) (OTCQX: EMHTF) ("Emerald") announced today that its Chief Financial Officer, Jenn Hepburn, will be stepping down from her position at Emerald, effective October 15, 2021, to pursue other interests.
Emerald Health Therapeutics Inc
Visit a quote page and your recently viewed tickers will be displayed here.
Signals & Forecast
Emerald Health Therapeutics, Inc. operates as a cannabis company. The firm engages in the production distribution, and sale of cannabis products. Its products include dried cannabis and cannabis oil, pants and seeds. The company was founded on Jul 31, 2007 and is headquartered in Vancouver, Canada.
Support, Risk & Stop-loss
There are mixed signals in the stock today. The Emerald Health Therapeutics stock holds sell signals from both short and long-term moving averages giving a more negative forecast for the stock. Also, there is a general sell signal from the relation between the two signals where the long-term average is above the short-term average.
Is Emerald Health Therapeutics stock A Buy?
Emerald Health Therapeutics finds support from accumulated volume at $0.0410 and this level may hold a buying opportunity as an upwards reaction can be expected when the support is being tested.
About Emerald Health Therapeutics
Emerald Health Therapeutics holds several positive signals, but we still don't find these to be enough for a buy candidate. At the current level, it should be considered as a hold candidate (hold or accumulate) in this position whilst awaiting further development.
Golden Star Signal
Emerald Health Therapeutics, Inc., together with its subsidiaries, engages in the production and sale of medical cannabis for medical purpose in Canada. It offers dried cannabis strains, pre-rolls, ingestible extracts, and cannabis oil products to its medical patients.
Top Fintech Company
This unique signal uses moving averages and adds special requirements that convert the very good Golden Cross into a Golden Star. This signal is rare and, in most cases, gives substantial returns. From 10 000+ stocks usually only a few will trigger a Golden Star Signal per day!